Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tripterygium wilfordii complex ester is a botanical drug preparation derived from the leaves (Folium) of the *Tripterygium wilfordii* Hook. f. plant, commonly known as Thunder God Vine. While traditional preparations of this plant typically utilize the root, the complex ester formulation specifically uses the leaves to extract active diterpenoids and alkaloids. It is primarily used in the treatment of rheumatoid arthritis and other autoimmune or inflammatory diseases. The drug exerts its therapeutic effects through potent immunosuppressive and anti-inflammatory actions, including the inhibition of pro-inflammatory cytokine production (such as TNF-α, IL-1, and IL-6), suppression of T-cell proliferation, and modulation of the NF-κB signaling pathway. Clinical studies have shown it to have comparable efficacy and safety to the more common root-derived polyglycoside preparations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tripterygium wilfordii complex ester.